Board appointment at Momenta
This article was originally published in Scrip
Momenta Pharmaceuticals (US) has named James Sulat chairman of the board. He succeeds Peter Barrett, who is leaving the board after five years, including serving as chairman since June 2005. Mr Sulat, who has been a member of Momenta's board of directors since June, most recently served as chief financial officer and director of Memory Pharmaceuticals, which signed a definitive agreement to be acquired by Roche in November.